IBDEI04X ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6236,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6236,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,6236,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,6236,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,6237,0)
 ;;=200.10^^43^437^86
 ;;^UTILITY(U,$J,358.3,6237,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6237,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,6237,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,6237,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,6238,0)
 ;;=273.3^^43^437^88
 ;;^UTILITY(U,$J,358.3,6238,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6238,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,6238,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,6238,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,6239,0)
 ;;=203.00^^43^437^97
 ;;^UTILITY(U,$J,358.3,6239,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6239,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,6239,1,5,0)
 ;;=5^Multiple Myeloma W/O Rem
 ;;^UTILITY(U,$J,358.3,6239,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,6240,0)
 ;;=203.01^^43^437^96
 ;;^UTILITY(U,$J,358.3,6240,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6240,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,6240,1,5,0)
 ;;=5^Multiple Myeloma In Remission
 ;;^UTILITY(U,$J,358.3,6240,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,6241,0)
 ;;=238.6^^43^437^100
 ;;^UTILITY(U,$J,358.3,6241,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6241,1,4,0)
 ;;=4^238.6
 ;;^UTILITY(U,$J,358.3,6241,1,5,0)
 ;;=5^Plasmacytoma Nos
 ;;^UTILITY(U,$J,358.3,6241,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,6242,0)
 ;;=205.00^^43^437^6
 ;;^UTILITY(U,$J,358.3,6242,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6242,1,4,0)
 ;;=4^205.00
 ;;^UTILITY(U,$J,358.3,6242,1,5,0)
 ;;=5^Aml, W/O Remission
 ;;^UTILITY(U,$J,358.3,6242,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,6243,0)
 ;;=205.01^^43^437^5
 ;;^UTILITY(U,$J,358.3,6243,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6243,1,4,0)
 ;;=4^205.01
 ;;^UTILITY(U,$J,358.3,6243,1,5,0)
 ;;=5^Aml, In Remission
 ;;^UTILITY(U,$J,358.3,6243,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,6244,0)
 ;;=205.10^^43^437^45
 ;;^UTILITY(U,$J,358.3,6244,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6244,1,4,0)
 ;;=4^205.10
 ;;^UTILITY(U,$J,358.3,6244,1,5,0)
 ;;=5^Cml, W/O Remission
 ;;^UTILITY(U,$J,358.3,6244,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,6245,0)
 ;;=205.11^^43^437^44
 ;;^UTILITY(U,$J,358.3,6245,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6245,1,4,0)
 ;;=4^205.11
 ;;^UTILITY(U,$J,358.3,6245,1,5,0)
 ;;=5^Cml, In Remission
 ;;^UTILITY(U,$J,358.3,6245,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,6246,0)
 ;;=289.0^^43^437^49
 ;;^UTILITY(U,$J,358.3,6246,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6246,1,4,0)
 ;;=4^289.0
 ;;^UTILITY(U,$J,358.3,6246,1,5,0)
 ;;=5^Erthryocytosis, Secondary
 ;;^UTILITY(U,$J,358.3,6246,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,6247,0)
 ;;=238.4^^43^437^101
 ;;^UTILITY(U,$J,358.3,6247,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6247,1,4,0)
 ;;=4^238.4
 ;;^UTILITY(U,$J,358.3,6247,1,5,0)
 ;;=5^Polycytheria Rubra Vera
 ;;^UTILITY(U,$J,358.3,6247,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,6248,0)
 ;;=V58.61^^43^437^122
 ;;^UTILITY(U,$J,358.3,6248,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6248,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,6248,1,5,0)
 ;;=5^Warfarin/Coumadin Use
 ;;^UTILITY(U,$J,358.3,6248,2)
 ;;=Warfarin/Coumadin Use^303459
 ;;^UTILITY(U,$J,358.3,6249,0)
 ;;=282.49^^43^437^111
 ;;^UTILITY(U,$J,358.3,6249,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6249,1,4,0)
 ;;=4^282.49
 ;;^UTILITY(U,$J,358.3,6249,1,5,0)
 ;;=5^Thalassemia Nec
 ;;^UTILITY(U,$J,358.3,6249,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,6250,0)
 ;;=289.89^^43^437^15
 ;;^UTILITY(U,$J,358.3,6250,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6250,1,4,0)
 ;;=4^289.89
 ;;^UTILITY(U,$J,358.3,6250,1,5,0)
 ;;=5^Blood Diseases Nec
 ;;^UTILITY(U,$J,358.3,6250,2)
 ;;=^329887
 ;;^UTILITY(U,$J,358.3,6251,0)
 ;;=238.79^^43^437^82
 ;;^UTILITY(U,$J,358.3,6251,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6251,1,4,0)
 ;;=4^238.79
 ;;^UTILITY(U,$J,358.3,6251,1,5,0)
 ;;=5^LYMPH/HEMATPOITC TIS NEC
 ;;^UTILITY(U,$J,358.3,6251,2)
 ;;=^334033
 ;;^UTILITY(U,$J,358.3,6252,0)
 ;;=287.30^^43^437^102
 ;;^UTILITY(U,$J,358.3,6252,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6252,1,4,0)
 ;;=4^287.30
 ;;^UTILITY(U,$J,358.3,6252,1,5,0)
 ;;=5^Primary Thrombocytopenia
 ;;^UTILITY(U,$J,358.3,6252,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,6253,0)
 ;;=288.09^^43^437^2
 ;;^UTILITY(U,$J,358.3,6253,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6253,1,4,0)
 ;;=4^288.09
 ;;^UTILITY(U,$J,358.3,6253,1,5,0)
 ;;=5^Agranulocytosis
 ;;^UTILITY(U,$J,358.3,6253,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,6254,0)
 ;;=V10.21^^43^437^55
 ;;^UTILITY(U,$J,358.3,6254,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6254,1,4,0)
 ;;=4^V10.21
 ;;^UTILITY(U,$J,358.3,6254,1,5,0)
 ;;=5^H/O Laryngeal Cancer
 ;;^UTILITY(U,$J,358.3,6254,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,6255,0)
 ;;=284.2^^43^437^98
 ;;^UTILITY(U,$J,358.3,6255,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6255,1,4,0)
 ;;=4^284.2
 ;;^UTILITY(U,$J,358.3,6255,1,5,0)
 ;;=5^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,6255,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,6256,0)
 ;;=202.40^^43^437^68
 ;;^UTILITY(U,$J,358.3,6256,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6256,1,4,0)
 ;;=4^202.40
 ;;^UTILITY(U,$J,358.3,6256,1,5,0)
 ;;=5^Hairy Cell Leukemia,Unspecified site
 ;;^UTILITY(U,$J,358.3,6256,2)
 ;;=^69587
 ;;^UTILITY(U,$J,358.3,6257,0)
 ;;=287.49^^43^437^113
 ;;^UTILITY(U,$J,358.3,6257,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6257,1,4,0)
 ;;=4^287.49
 ;;^UTILITY(U,$J,358.3,6257,1,5,0)
 ;;=5^Thrombocytopenia,Drug Induced
 ;;^UTILITY(U,$J,358.3,6257,2)
 ;;=^339610
 ;;^UTILITY(U,$J,358.3,6258,0)
 ;;=285.9^^43^437^9
 ;;^UTILITY(U,$J,358.3,6258,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6258,1,4,0)
 ;;=4^285.9
 ;;^UTILITY(U,$J,358.3,6258,1,5,0)
 ;;=5^Anemia NOS
 ;;^UTILITY(U,$J,358.3,6258,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,6259,0)
 ;;=287.9^^43^437^14
 ;;^UTILITY(U,$J,358.3,6259,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6259,1,4,0)
 ;;=4^287.9
 ;;^UTILITY(U,$J,358.3,6259,1,5,0)
 ;;=5^Bleeding Disorder NOS
 ;;^UTILITY(U,$J,358.3,6259,2)
 ;;=^123920
 ;;^UTILITY(U,$J,358.3,6260,0)
 ;;=286.9^^43^437^46
 ;;^UTILITY(U,$J,358.3,6260,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6260,1,4,0)
 ;;=4^286.9
 ;;^UTILITY(U,$J,358.3,6260,1,5,0)
 ;;=5^Coagulation Defect NOS
 ;;^UTILITY(U,$J,358.3,6260,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,6261,0)
 ;;=281.9^^43^437^48
 ;;^UTILITY(U,$J,358.3,6261,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6261,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,6261,1,5,0)
 ;;=5^Deficiency Anemia NOS
 ;;^UTILITY(U,$J,358.3,6261,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,6262,0)
 ;;=280.9^^43^437^80
 ;;^UTILITY(U,$J,358.3,6262,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6262,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,6262,1,5,0)
 ;;=5^Iron Deficiency Anemia NOS
 ;;^UTILITY(U,$J,358.3,6262,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,6263,0)
 ;;=287.5^^43^437^112
 ;;^UTILITY(U,$J,358.3,6263,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6263,1,4,0)
 ;;=4^287.5
 ;;^UTILITY(U,$J,358.3,6263,1,5,0)
 ;;=5^Thrombocytopenia NOS
 ;;^UTILITY(U,$J,358.3,6263,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,6264,0)
 ;;=289.9^^43^437^114
 ;;^UTILITY(U,$J,358.3,6264,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6264,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,6264,1,5,0)
 ;;=5^Thrombocytosis NOS
 ;;^UTILITY(U,$J,358.3,6264,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,6265,0)
 ;;=195.0^^43^437^69
 ;;^UTILITY(U,$J,358.3,6265,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6265,1,4,0)
 ;;=4^195.0
 ;;^UTILITY(U,$J,358.3,6265,1,5,0)
 ;;=5^Head/Face/Neck CA
 ;;^UTILITY(U,$J,358.3,6265,2)
 ;;=^267306
 ;;^UTILITY(U,$J,358.3,6266,0)
 ;;=202.80^^43^437^84
 ;;^UTILITY(U,$J,358.3,6266,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6266,1,4,0)
 ;;=4^202.80
 ;;^UTILITY(U,$J,358.3,6266,1,5,0)
 ;;=5^Lymphoma NEC Unsp Site
 ;;^UTILITY(U,$J,358.3,6266,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,6267,0)
 ;;=193.^^43^437^118
 ;;^UTILITY(U,$J,358.3,6267,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6267,1,4,0)
 ;;=4^193.
 ;;^UTILITY(U,$J,358.3,6267,1,5,0)
 ;;=5^Thyroid CA
 ;;^UTILITY(U,$J,358.3,6267,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,6268,0)
 ;;=465.9^^43^438^69
 ;;^UTILITY(U,$J,358.3,6268,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6268,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,6268,1,5,0)
 ;;=5^URI
 ;;^UTILITY(U,$J,358.3,6268,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,6269,0)
 ;;=462.^^43^438^60
 ;;^UTILITY(U,$J,358.3,6269,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6269,1,4,0)
 ;;=4^462.
 ;;^UTILITY(U,$J,358.3,6269,1,5,0)
 ;;=5^Sore Throat
 ;;^UTILITY(U,$J,358.3,6269,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,6270,0)
 ;;=466.0^^43^438^3
 ;;^UTILITY(U,$J,358.3,6270,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6270,1,4,0)
 ;;=4^466.0
 ;;^UTILITY(U,$J,358.3,6270,1,5,0)
 ;;=5^Bronchitis,Acute
 ;;^UTILITY(U,$J,358.3,6270,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,6271,0)
 ;;=112.1^^43^438^79
 ;;^UTILITY(U,$J,358.3,6271,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6271,1,4,0)
 ;;=4^112.1
 ;;^UTILITY(U,$J,358.3,6271,1,5,0)
 ;;=5^Vulvovaginitis,Candidal
 ;;^UTILITY(U,$J,358.3,6271,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,6272,0)
 ;;=616.0^^43^438^13
 ;;^UTILITY(U,$J,358.3,6272,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6272,1,4,0)
 ;;=4^616.0
 ;;^UTILITY(U,$J,358.3,6272,1,5,0)
 ;;=5^Cervicitis
 ;;^UTILITY(U,$J,358.3,6272,2)
 ;;=^21925
 ;;^UTILITY(U,$J,358.3,6273,0)
 ;;=599.0^^43^438^70
 ;;^UTILITY(U,$J,358.3,6273,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6273,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,6273,1,5,0)
 ;;=5^UTI
 ;;^UTILITY(U,$J,358.3,6273,2)
 ;;=UTI^124436
 ;;^UTILITY(U,$J,358.3,6274,0)
 ;;=460.^^43^438^46
 ;;^UTILITY(U,$J,358.3,6274,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6274,1,4,0)
 ;;=4^460.
